Nurse-To-Family Telehealth

Nurse-to-Family Telehealth for Pediatric Transfers: A Randomized Controlled Pilot Trial

This study will be a pilot test of using telehealth to allow nurses to connect with parents/guardians of pediatric patients who are being transferred between hospitals.

Study Overview

• Status: Completed
• Conditions: Pediatric Disorder
• Intervention / Treatment: Behavioral: Nurse-to-Family Video Chat

• Study Type: Interventional
• Enrollment (Actual): 291
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • California
    • Sacramento, California, United States, 95817
      • University of California Davis Medical Center

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 1 week to 18 years (Child, Adult, Older Adult)
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

Children who:

• are aged 8 days to <=18 years
• present to a participating community hospital ED
• are accepted for inter-facility transfer to UC Davis
• are assigned to UC Davis unit D10, D7, or T6
• have an English-speaking adult parent/guardian at the bedside

Exclusion Criteria:

• does not have an English-speaking adult parent/guardian at the bedside

For parent surveys --

Inclusion Criteria:

• are parents/guardians of the eligible patients (described above)
• are age 18 years and older
• are English-speaking

Exclusion Criteria:

• are age less than 18 years
• have a preferred language that is other than English

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Control; Standard of care
Experimental: Intervention; Parents have the option to use telehealth to virtually connect with the nurse before transfer	Behavioral: Nurse-to-Family Video Chat; A Nurse-To-Family Video Chat will be offered to parents/guardians to virtually connect with their post-transfer nurse; this intervention is changing the behavior of how providers deliver healthcare and how parents/guardians engage in their child's care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Assignment Adherence	Percentage of eligible patients for whom the protocol assignment (telehealth vs standard of care) was followed	Day 0

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Fidelity: Percentage of Telehealth Initiated Before Arrival	Whether or not a telehealth connection was initiated prior to patient's arrival to UC Davis hospital. Time of telehealth initiation, if applicable, was obtained from the ExtendedCare (telehealth platform) reporting system. Time of patient arrival was obtained from the electronic health record.	Day 0
Survey Completion Rate (%)	Percentage of completed surveys among eligible respondents	Day 0

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Family-Centered Care	Unit of measure: mean score Measure/Tool: Family-Centered Care Experience (FACCE)	Day 0
Family Experience	Unit of measure: mean score Measure/Tool: Emergency Department CAHPS (Consumer Assessment of Healthcare Providers and Systems) 2 items measuring overall experience	Day 0
Parent Acute Stress	Unit of measure: mean score Measure/Tool: (parent-reported survey) PROMIS 7-item Emotional Distress: Anxiety	Day 0
Parent Distress	Unit of measure: mean score Measure/Tool: (parent-reported survey) PROMIS 7-item Emotional Distress: Anxiety	Day 30
Change in Level of Care	Unit of measure: Percentage of subjects with change in level of care among eligible subjects. subjects - Definition: (chart review dichotomous outcome) Switching from an acute care unit or service to an intensive care unit or service, and vice versa.	Day 0

Collaborators and Investigators

• Sponsor: University of California, Davis

Study record dates

Study Major Dates

• Study Start (Actual): January 3, 2023
• Primary Completion (Actual): July 2, 2023
• Study Completion (Actual): July 23, 2023

Study Registration Dates

• First Submitted: October 18, 2022
• First Submitted That Met QC Criteria: October 22, 2022
• First Posted (Actual): October 26, 2022

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: January 10, 2025
• Last Verified: January 1, 2025

More Information

Terms related to this study

• Other Study ID Numbers: 1062184

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No